18/09/2015 - General information
Some time ago it was believed that new genes originated, at least partially, from other genes; for instance, from the duplication of existing genes. But recently it has been seen that there are certain genes, those called de novo genes, that originate in genomic regions that didn’t contain any genes previously. A study published in arXiv.org, led by Mar Albà, the coordinator of the Group on Evolutionary Genomics from the Research Programme on Biomedical Informatics (GRIB) from IMIM and the UPF and an ICREA Professor, and with the collaboration of scientists from different centres at the PRBB (Barcelona Biomedical Research Park), has revealed there are hundreds of de novo genes originated in humans, many of which where unknown until now. Some of these genes are coded through small proteins that are expressed in the brain or in germinal cells.
12/09/2012 - General information
The project- based on a collaboration agreement between the Barcelona Science Park (PCB) and the companies SOM Biotech and Metasbio– will enable the discovery of new therapeutic applications of previously existing drugs (repurposing), especially in areas of great medical need and market potential, such as the central nervous system, oncology and orphan diseases.
21/06/2012 - General information
"Connect, partner and innovate". This is the slogan for the twentieth edition of the BIO International Convention, held 18 to 21 June 2012 in the city of Boston (Massachusetts, United States). BIO is the most important international business meeting in the biotechnology arena. This year, it will bring together more than 15,000 delegates from 65 countries, more than 900 exhibitors and 1,800 companies. In addition to the exhibition area, it also features a Business Forum for partnering meetings, which in 2011 generated more than 21,000 one-to-one meetings.
Més informació "GRIB participated at BIO Boston 2012, the top biotechnology convention in the world"
21/05/2012 - General information
After one week of intensive training, the closing event of the INBIOMEDvision Training Challenge successfully took place in Barcelona. This training gathered together two teams of 5 PhD students with different nationalities and scientific backgrounds (chemists, medical doctors, informatics, mathematics, biologists etc.) to work on two case studies related with health sciences during one week at the Monastery of Les Avellanes (Lleida, Spain).
29/02/2012 - General information
The prototype of a knowledge tool developed by the Open PHACTS Consortium has proven useful by identifying relevant information in a matter of seconds, when a traditional search could take days. It will provide information on small molecules, their pharmacological profile, pharmacokinetics, etc. from multiple sources available on the Internet.
28/01/2011 - General information
Laura López, Cristian Obiol-Pardo and Jana Selent, members of the Computer Aided Drug Design (CADD) group of the Biomedical IT Research Group (GRIB, of the UPF-IMIM) have won first prize for the best prediction of the ligands established by the GPCR protein, a molecule which intervenes in many cell processes and interacts with half of all known drugs.
Més informació "GRIB Members Win an International Competition"
28/05/2010 - General information
Molecular Discovery Ltd, one of the world leader companies in chemoinformatics and services for the pharmaceutical industry has launched to the market the software Pentacle, developed at the Computer of Assisted Drug Design (CADD) laboratory by Ángel Durán and Manuel Pastor.
15/04/2010 - General information
The Evolutionary Genomics group of GRIB (IMIM- UPF), led by Mar Albà, has published at the journal Genome Research a study that shows, using a comparative genomics approach, that many more amino acid tandem repeats in human proteins than previously suspected are likely to be functional.
01/03/2010 - General information
On 15 February, the international journal Bioinformatics, one of the best in the field of mathematics and computational biology, published an article on a web application developed by the Laboratorio de Quimiogenómica, directed by Jordi Mestres, which is part of the IMIM-UPF Biomedicine IT Research Group (GRIB).
Més informació "iPHACE, Software to Visually Explore Pharmacological Space"
23/02/2010 - General information
The Innovative Medicines Initiative (IMI) funds for 5 years a consortium consisting of 13 European pharmaceutical companies and 12 academic groups and SMEs to develop information technologies-based solutions for improved toxicity prediction of new drug candidates. The academic coordination of the project is in charge of Ferran Sanz, Director of GRIB (IMIM-UPF).
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
